Table 6 The undiscounted lifetime cost of CP stratified by level of physical disability
From: Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis
Health system perspective | Societal perspective | |
|---|---|---|
Mild (GMFCS level I/II) | 33,524 | 3,581,722 |
Moderate (GMFCS level III) | 70,923 | 4,500,094 |
Severe (GMFCS level IV/V) | 61,378 | 2,208,153 |